91 related articles for article (PubMed ID: 26299169)
1. Glucose homeostasis changes and pancreatic β-cell proliferation after switching to cyclosporin in tacrolimus-induced diabetes mellitus.
Rodríguez-Rodríguez AE; Triñanes J; Porrini E; Velázquez-García S; Fumero C; Vega-Prieto MJ; Díez-Fuentes ML; Luis Lima S; Salido E; Torres A
Nefrologia; 2015; 35(3):264-72. PubMed ID: 26299169
[TBL] [Abstract][Full Text] [Related]
2. The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats.
Rodriguez-Rodriguez AE; Triñanes J; Velazquez-Garcia S; Porrini E; Vega Prieto MJ; Diez Fuentes ML; Arevalo M; Salido Ruiz E; Torres A
Am J Transplant; 2013 Jul; 13(7):1665-75. PubMed ID: 23651473
[TBL] [Abstract][Full Text] [Related]
3. Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells.
Triñanes J; Rodriguez-Rodriguez AE; Brito-Casillas Y; Wagner A; De Vries APJ; Cuesto G; Acebes A; Salido E; Torres A; Porrini E
Am J Transplant; 2017 Nov; 17(11):2829-2840. PubMed ID: 28432716
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the mTOR pathway: A new mechanism of β cell toxicity induced by tacrolimus.
Rodriguez-Rodriguez AE; Donate-Correa J; Rovira J; Cuesto G; Luis-Ravelo D; Fernandes MX; Acevedo-Arozena A; Diekmann F; Acebes A; Torres A; Porrini E
Am J Transplant; 2019 Dec; 19(12):3240-3249. PubMed ID: 31152486
[TBL] [Abstract][Full Text] [Related]
5. Induction of diabetes by Tacrolimus in a phenotypic model of obesity and metabolic syndrome.
Teixidó-Trujillo S; Porrini E; Menéndez-Quintanal LM; Torres-Ramírez A; Fumero C; Rodríguez-Rodríguez AE
Front Endocrinol (Lausanne); 2024; 15():1388361. PubMed ID: 38745946
[TBL] [Abstract][Full Text] [Related]
6. Activation of the dual-leucine-zipper-bearing kinase and induction of beta-cell apoptosis by the immunosuppressive drug cyclosporin A.
Plaumann S; Blume R; Börchers S; Steinfelder HJ; Knepel W; Oetjen E
Mol Pharmacol; 2008 Mar; 73(3):652-9. PubMed ID: 18042735
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of diabetes mellitus induced with FK506 in SD rats models.
Li QY; Li F; Sun JH; Chi YY; Yin HS; Liu SQ; Mei YH
Immunopharmacol Immunotoxicol; 2009; 31(4):675-81. PubMed ID: 19874240
[TBL] [Abstract][Full Text] [Related]
8. Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates β-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes.
Akarte AS; Srinivasan BP; Gandhi S
J Diabetes Complications; 2012; 26(4):266-74. PubMed ID: 22626875
[TBL] [Abstract][Full Text] [Related]
9. [Calcineurin inhibitors and mechanisms that are responsible for the appearance of post-transplant diabetes mellitus].
Ippoliti GB; Viganò M
G Ital Nefrol; 2003; 20 Suppl 25():S11-4. PubMed ID: 14523907
[TBL] [Abstract][Full Text] [Related]
10. Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat.
Khan S; Jena GB
Chem Biol Interact; 2014 Apr; 213():1-12. PubMed ID: 24530320
[TBL] [Abstract][Full Text] [Related]
11. Increased macrophage activation inhibited by tacrolimus in the kidney of diabetic rats.
Wu Y; Wang Y; Qi X; Zhang P; Zhang C; Zhang W
Nephron Exp Nephrol; 2014; 128(1-2):46-56. PubMed ID: 25376933
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of Prosopis glandulosa as antidiabetic treatment in rat models of diabetes and insulin resistance.
George C; Lochner A; Huisamen B
J Ethnopharmacol; 2011 Sep; 137(1):298-304. PubMed ID: 21645608
[TBL] [Abstract][Full Text] [Related]
13. DC260126, a small-molecule antagonist of GPR40, improves insulin tolerance but not glucose tolerance in obese Zucker rats.
Zhang X; Yan G; Li Y; Zhu W; Wang H
Biomed Pharmacother; 2010 Nov; 64(9):647-51. PubMed ID: 20888730
[TBL] [Abstract][Full Text] [Related]
14. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
Adewole SO; Ojewole JA
Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin improves glucose metabolism and pancreatic β-cell damage in experimental diabetic rats.
Chen LN; Sun Q; Liu SQ; Hu H; Lv J; Ji WJ; Wang M; Chen MX; Zhou J
Mol Med Rep; 2015 Oct; 12(4):5391-8. PubMed ID: 26126591
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
Batista F; Auyanet I; Torregrosa JV; Oppenheimer F
Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
[TBL] [Abstract][Full Text] [Related]
17. Distinct inhibitory effects of tacrolimus and cyclosporin a on calcineurin phosphatase activity.
Fukudo M; Yano I; Masuda S; Okuda M; Inui K
J Pharmacol Exp Ther; 2005 Feb; 312(2):816-25. PubMed ID: 15383634
[TBL] [Abstract][Full Text] [Related]
18. Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice.
Tamura K; Minami K; Kudo M; Iemoto K; Takahashi H; Seino S
PLoS One; 2015; 10(5):e0126003. PubMed ID: 25938469
[TBL] [Abstract][Full Text] [Related]
19. Effect of Silymarin in Pdx-1 expression and the proliferation of pancreatic β-cells in a pancreatectomy model.
Soto C; Raya L; Juárez J; Pérez J; González I
Phytomedicine; 2014 Feb; 21(3):233-9. PubMed ID: 24176839
[TBL] [Abstract][Full Text] [Related]
20. Effect of tacrolimus dosing on glucose metabolism in an experimental rat model.
Malinowski M; Pratschke J; Lock J; Neuhaus P; Stockmann M
Ann Transplant; 2010; 15(3):60-5. PubMed ID: 20877268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
